Table 2 Clinical characteristics of ulcerative colitis patients with high levels of serum IgG4.

From: High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease

Patients

Sex

Serum IgG4 (g/L)

Serum IgG (g/L)

Distribution

Disease severity

Treatment

SILBNRAT

1

M

1.51

13.5

E1

Mild

5-ASA

Y

2

F

1.54

16.5

E3

Moderate

5-ASA

NA

3

F

1.54

17.2

E3

Moderate

5-ASA

Y

4

M

2.06

21.7

E3

Moderate

5-ASA

NA

5

F

2.61

21.7

E3

Moderate

5-ASA

N

6

F

2.44

19.3

E3

Moderate

5-ASA

N

7

M

1.61

18.3

E3

Moderate

GC

NA

8

M

3.1

29.3

E3

Severe

GC

N

9

M

1.83

11.6

E3

Severe

GC

Y

10

M

1.6

13.8

E3

Severe

GC

NA

  1. SILBNRAT: Serum IgG4 level back to normal range after treatment; M, male; F, female; E1, proctitis; E2, left sided; E3, extensive; 5-ASA, 5-aminosalicylic acid; GC, glucocorticoid; Y, yes; N, no; NA, not available.